IPOs: It's all about timing

Shanghai Fosun Pharmaceutical last week pushed back the launch of its US$600 million initial public offering from October 11 to, most likely, today - possibly putting it on track for an accelerated marketing. (See "Take your guess for Fosun Pharma pricing", Money Post, April 30).

The selling phase of an IPO is often delayed. Many deals are also postponed midway towards the closing of their book of demand, and prior to the final pricing stage.

via Business feed http://www.scmp.com/business/money/markets-investing/article/1059613/ipos-its-all-about-timing